Advanced Synthesis & Catalysis · 2012 · 111 citations · 44 references
Spirooxindole‐type PyranopyrimidinesOrganic ChemistryChemistryMedicinal ChemistryBroad‐spectrum Anticancer PotencyDiversity Oriented SynthesisAnti-cancer AgentRadiation OncologyVarious Cancer CellsDerivativesDiversity-oriented SynthesisSelective Anticancer AgentsDrug DevelopmentPharmacologyEnantioselective SynthesisNatural SciencesChiral Spirooxindole‐pyranopyrimidinesMedicineSynthetic ChemistryDrug Discovery
Abstract Due to the lack of tumor‐specific anticancer agents, the discovery and development of new types of highly selective anticancer agents is still a very urgent topic. Herein, we present our contribution to concise construction of novel chiral spirooxindole‐type pyranopyrimidines exhibiting a unique profile of biological activities. We have found that this new type of spiro alkaloid could inhibit the proliferation of various cancer cells in a preliminary biological evaluation. These findings suggested that spirooxindole‐type pyranopyrimidines, developed by an asymmetric Michael/cyclization strategy, can potentially serve as a new kind of anticancer candidate.
44
Ke Ding, Yipin Lu, Zaneta Nikolovska‐Coleska et al. · Journal of Medicinal Chemistry · 2006 · 681 citations · Full text
Combinatorial Chemistry, Mdm2-p53 Interaction, Chemoprevention Strategy +19